世界のミトキサントロン市場 2019年

QYResearchが発行した調査報告書(QYR20FB02192)
◆英語タイトル:Global Mitoxantrone Market Professional Survey Report 2019
◆商品コード:QYR20FB02192
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月5日(※2024年版があります。お問い合わせください。)
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、ミトキサントロンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、5 mg凍結乾燥粉末、20 mg / 10 mLマルチドーズバイアル、25 mg / 12.5 mLマルチドーズバイアル、30 mg / 15 mLマルチドーズバイアルに、用途別には、特定種類がん、多発性硬化症(MS)にセグメント区分し、ミトキサントロンの世界市場を分析しました。


・エグゼクティブ・サマリー
・ミトキサントロンの世界市場概要
・ミトキサントロンの製造コスト構成分析
・ミトキサントロンの開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・ミトキサントロンの地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・ミトキサントロンのセグメント分析(種類別)
(5 mg凍結乾燥粉末、20 mg / 10 mLマルチドーズバイアル、25 mg / 12.5 mLマルチドーズバイアル、30 mg / 15 mLマルチドーズバイアル)
・ミトキサントロンのセグメント分析(用途別)
(特定種類がん、多発性硬化症(MS))
・ミトキサントロンの主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Pfizer、Mylan、Teva、Fresenius Kabi、West-Ward Pharmaceuticals、Sichuan Sunnyhope Pharmaceutical、Shandong Luoxin Pharmaceutical、Baxter)
・ミトキサントロンの市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent.
The global Mitoxantrone market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Mitoxantrone volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mitoxantrone market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Mitoxantrone in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Mitoxantrone manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Mylan
Teva
Fresenius Kabi
West-Ward Pharmaceuticals
Sichuan Sunnyhope Pharmaceutical
Shandong Luoxin Pharmaceutical
Baxter

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
5 mg Lyophilized powder
20 mg/10 mL multidose vial
25 mg/12.5 mL multidose vial
30 mg/15 mL multidose vial

Segment by Application
Certain types of cancer
Multiple sclerosis (MS)

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Mitoxantrone
1.1 Definition of Mitoxantrone
1.2 Mitoxantrone Segment by Type
1.2.1 Global Mitoxantrone Production Growth Rate Comparison by Types (2014-2025)
1.2.2 5 mg Lyophilized powder
1.2.3 20 mg/10 mL multidose vial
1.2.4 25 mg/12.5 mL multidose vial
1.2.5 30 mg/15 mL multidose vial
1.3 Mitoxantrone Segment by Applications
1.3.1 Global Mitoxantrone Consumption Comparison by Applications (2014-2025)
1.3.2 Certain types of cancer
1.3.3 Multiple sclerosis (MS)
1.4 Global Mitoxantrone Overall Market
1.4.1 Global Mitoxantrone Revenue (2014-2025)
1.4.2 Global Mitoxantrone Production (2014-2025)
1.4.3 North America Mitoxantrone Status and Prospect (2014-2025)
1.4.4 Europe Mitoxantrone Status and Prospect (2014-2025)
1.4.5 China Mitoxantrone Status and Prospect (2014-2025)
1.4.6 Japan Mitoxantrone Status and Prospect (2014-2025)
1.4.7 Southeast Asia Mitoxantrone Status and Prospect (2014-2025)
1.4.8 India Mitoxantrone Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Mitoxantrone
2.3 Manufacturing Process Analysis of Mitoxantrone
2.4 Industry Chain Structure of Mitoxantrone

3 Development and Manufacturing Plants Analysis of Mitoxantrone
3.1 Capacity and Commercial Production Date
3.2 Global Mitoxantrone Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Mitoxantrone
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Mitoxantrone Production and Capacity Analysis
4.2 Mitoxantrone Revenue Analysis
4.3 Mitoxantrone Price Analysis
4.4 Market Concentration Degree

5 Mitoxantrone Regional Market Analysis
5.1 Mitoxantrone Production by Regions
5.1.1 Global Mitoxantrone Production by Regions
5.1.2 Global Mitoxantrone Revenue by Regions
5.2 Mitoxantrone Consumption by Regions
5.3 North America Mitoxantrone Market Analysis
5.3.1 North America Mitoxantrone Production
5.3.2 North America Mitoxantrone Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Mitoxantrone Import and Export
5.4 Europe Mitoxantrone Market Analysis
5.4.1 Europe Mitoxantrone Production
5.4.2 Europe Mitoxantrone Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Mitoxantrone Import and Export
5.5 China Mitoxantrone Market Analysis
5.5.1 China Mitoxantrone Production
5.5.2 China Mitoxantrone Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Mitoxantrone Import and Export
5.6 Japan Mitoxantrone Market Analysis
5.6.1 Japan Mitoxantrone Production
5.6.2 Japan Mitoxantrone Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Mitoxantrone Import and Export
5.7 Southeast Asia Mitoxantrone Market Analysis
5.7.1 Southeast Asia Mitoxantrone Production
5.7.2 Southeast Asia Mitoxantrone Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Mitoxantrone Import and Export
5.8 India Mitoxantrone Market Analysis
5.8.1 India Mitoxantrone Production
5.8.2 India Mitoxantrone Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Mitoxantrone Import and Export

6 Mitoxantrone Segment Market Analysis (by Type)
6.1 Global Mitoxantrone Production by Type
6.2 Global Mitoxantrone Revenue by Type
6.3 Mitoxantrone Price by Type

7 Mitoxantrone Segment Market Analysis (by Application)
7.1 Global Mitoxantrone Consumption by Application
7.2 Global Mitoxantrone Consumption Market Share by Application (2014-2019)

8 Mitoxantrone Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Mitoxantrone Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Mitoxantrone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Mylan
8.2.1 Mylan Mitoxantrone Production Sites and Area Served
8.2.2 Mylan Product Introduction, Application and Specification
8.2.3 Mylan Mitoxantrone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Teva
8.3.1 Teva Mitoxantrone Production Sites and Area Served
8.3.2 Teva Product Introduction, Application and Specification
8.3.3 Teva Mitoxantrone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Fresenius Kabi
8.4.1 Fresenius Kabi Mitoxantrone Production Sites and Area Served
8.4.2 Fresenius Kabi Product Introduction, Application and Specification
8.4.3 Fresenius Kabi Mitoxantrone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 West-Ward Pharmaceuticals
8.5.1 West-Ward Pharmaceuticals Mitoxantrone Production Sites and Area Served
8.5.2 West-Ward Pharmaceuticals Product Introduction, Application and Specification
8.5.3 West-Ward Pharmaceuticals Mitoxantrone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Sichuan Sunnyhope Pharmaceutical
8.6.1 Sichuan Sunnyhope Pharmaceutical Mitoxantrone Production Sites and Area Served
8.6.2 Sichuan Sunnyhope Pharmaceutical Product Introduction, Application and Specification
8.6.3 Sichuan Sunnyhope Pharmaceutical Mitoxantrone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Shandong Luoxin Pharmaceutical
8.7.1 Shandong Luoxin Pharmaceutical Mitoxantrone Production Sites and Area Served
8.7.2 Shandong Luoxin Pharmaceutical Product Introduction, Application and Specification
8.7.3 Shandong Luoxin Pharmaceutical Mitoxantrone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Baxter
8.8.1 Baxter Mitoxantrone Production Sites and Area Served
8.8.2 Baxter Product Introduction, Application and Specification
8.8.3 Baxter Mitoxantrone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Mitoxantrone Market
9.1 Global Mitoxantrone Market Trend Analysis
9.1.1 Global Mitoxantrone Market Size (Volume and Value) Forecast 2019-2025
9.2 Mitoxantrone Regional Market Trend
9.2.1 North America Mitoxantrone Forecast 2019-2025
9.2.2 Europe Mitoxantrone Forecast 2019-2025
9.2.3 China Mitoxantrone Forecast 2019-2025
9.2.4 Japan Mitoxantrone Forecast 2019-2025
9.2.5 Southeast Asia Mitoxantrone Forecast 2019-2025
9.2.6 India Mitoxantrone Forecast 2019-2025
9.3 Mitoxantrone Market Trend (Product Type)
9.4 Mitoxantrone Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Mitoxantrone Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

...

【掲載企業】

Pfizer、Mylan、Teva、Fresenius Kabi、West-Ward Pharmaceuticals、Sichuan Sunnyhope Pharmaceutical、Shandong Luoxin Pharmaceutical、Baxter

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のミトキサントロン市場 2019年(Global Mitoxantrone Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。